Home › Funds › BLI - Banque de Luxembourg Investments › AZN
BLI - Banque de Luxembourg Investments position in AZN
ASTRAZENECA PLC · Health Care
BLI - Banque de Luxembourg Investments reported holding 419,507 shares of AZN (ASTRAZENECA PLC) in its Q3 2026 13F filing — a position valued at US$69.8M, representing 2.22% of its reported portfolio and ranking #12 among its reported holdings. BLI - Banque de Luxembourg Investments has disclosed AZN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How BLI - Banque de Luxembourg Investments's AZN position evolved
BLI - Banque de Luxembourg Investments first disclosed a stake in AZN in Q1 2026 at 372,869 shares (US$69.0M). The position peaked in Q3 2026 at 419,507 shares, worth US$69.8M. Across 3 filings, BLI - Banque de Luxembourg Investments increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 419,507 shares valued at US$69.8M — an increase of 48,549 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 372.87K | $68.99M | New |
| Q2 2026 | 370.96K | $68.27M | Reduce |
| Q3 2026 | 419.51K | $69.85M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AZN and 13F data
AZN (ASTRAZENECA PLC) is a Health Care company. 68 other funds we track also report a position in AZN — the largest reported positions include INVESTOR AB (US$9.78B), Capital International Investors (US$6.49B), Norges Bank Investment Management (US$6.33B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AZN
- INVESTOR AB 51.59M sh · $9.78B · Q2 2026
- Capital International Investors 34.58M sh · $6.49B · Q2 2026
- Norges Bank Investment Management 33.86M sh · $6.33B · Q2 2026
- Capital World Investors 30.08M sh · $5.63B · Q2 2026
- Capital World Investors 30.08M sh · $5.63B · Q2 2026
- Wellington Management Group 28.54M sh · $5.36B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 28.54M sh · $5.36B · Q2 2026
- Legal & General Investment Management America 25.75M sh · $4.82B · Q2 2026
- VANGUARD ASSET MANAGEMENT, Ltd 18.71M sh · $3.49B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 18.10M sh · $3.43B · Q2 2026
- PRUDENTIAL PLC 170.57K sh · $3.19B · Q2 2026
- Amundi US 16.42M sh · $3.11B · Q2 2026
More on BLI - Banque de Luxembourg Investments
FAQ
How long has BLI - Banque de Luxembourg Investments held AZN?
BLI - Banque de Luxembourg Investments has disclosed AZN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is BLI - Banque de Luxembourg Investments's current position in AZN?
As of Q3 2026, BLI - Banque de Luxembourg Investments holds 419.51K shares of AZN (ASTRAZENECA PLC), valued at $69.85M, representing 2.22% of its reported portfolio and ranking #12.
Has BLI - Banque de Luxembourg Investments been buying or selling AZN?
In the latest 13F filing (Q3 2026), BLI - Banque de Luxembourg Investments increased its position in AZN. The position peaked in Q3 2026 at 419.51K shares.
Which other funds hold AZN?
Other major institutional holders of AZN include INVESTOR AB, Capital International Investors, Norges Bank Investment Management, among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.